View Item 

Show simple item record

Perspectives in the study of the political economy of COVID-19 vaccine regulation

dc.contributor.authorFonseca, Elize M. da
dc.contributor.authorJarman, Holly
dc.contributor.authorKing, Elizabeth J.
dc.contributor.authorGreer, Scott L.
dc.date.accessioned2022-11-09T21:19:01Z
dc.date.available2023-11-09 16:19:00en
dc.date.available2022-11-09T21:19:01Z
dc.date.issued2022-10
dc.identifier.citationFonseca, Elize M. da; Jarman, Holly; King, Elizabeth J.; Greer, Scott L. (2022). "Perspectives in the study of the political economy of COVID-19 vaccine regulation." Regulation & Governance 16(4): 1283-1289.
dc.identifier.issn1748-5983
dc.identifier.issn1748-5991
dc.identifier.urihttps://hdl.handle.net/2027.42/175105
dc.description.abstractVaccines against SARS-CoV-2 continue to be developed at an astonishingly quick speed and the early ones, like Pfizer and Moderna, have been shown to be more effective than many public health scientists had dared to hope. As COVID-19 vaccine research continues to progress, the world’s eyes are turning toward medicine regulators. COVID-19 vaccines need to be authorized for use in each country in which the pharmaceutical industry intends to commercialize its product. This results in a patchwork of regulations that can influence the speed at which products are launched and the standards that govern them. In this research forum article, we discuss several key questions about COVID-19 vaccine regulations that should shape research on the next stage of the pandemic response. We call for a research agenda that looks into the political economy of pharmaceutical regulation, particularly from a comparative perspective, including Global South countries.
dc.publisherJohn Wiley & Sons Australia, Ltd
dc.subject.otherpharmaceutical regulation
dc.subject.othercomparative politics
dc.subject.otherCOVID-19
dc.subject.otherpolitical economy
dc.titlePerspectives in the study of the political economy of COVID-19 vaccine regulation
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelPolitical Science
dc.subject.hlbtoplevelGovernment, Politics, and Law
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/175105/1/rego12413.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/175105/2/rego12413_am.pdf
dc.identifier.doi10.1111/rego.12413
dc.identifier.sourceRegulation & Governance
dc.identifier.citedreferenceReynolds E, Halasz S, Pleitgen F, Isaac L ( 2020 ). UK Becomes First Country to Authorize Pfizer/BioNTech’s Covid-19 Vaccine, First Shots Roll Out Next Week. CNN, 3 Dec. [Last accessed 19 May 2021.] Available from URL: https://edition.cnn.com/2020/12/02/uk/pfizer-coronavirus-vaccine-uk-intl-hnk/index.html.
dc.identifier.citedreferenceLeBlanc P ( 2020 ) Trump Claims White House Can Overrule FDA’s Attempt to Toughen Guidelines for Coronavirus Vaccine. CNN, 24 Sep. [Last accessed 19 May 2021.] Available from URL: https://edition.cnn.com/2020/09/23/politics/trump-fda-coronavirus-vaccine/index.html.
dc.identifier.citedreferenceManskar N ( 2020 ) European Officials Say UK Rushed Approval of Pfizer COVID-19 Vaccine. New York Post, 2 Dec.
dc.identifier.citedreferenceMaor M ( 2011 ) Organizational Reputations and the Observability of Public Warnings in 10 Pharmaceutical Markets. Governance 24 ( 3 ), 557 – 582.
dc.identifier.citedreferenceNational Academies of Sciences Engineering and Medicine ( 2019 ) Regulating Medicines in a Globalized World: The Need for Increased Reliance Among Regulators. [Last accessed 19 May 2021.] Available from URL: https://doi.org/10.17226/25594.
dc.identifier.citedreferenceNature ( 2020 ) Eyes of the World Are on Medicines Regulators. Nature 588, 195.
dc.identifier.citedreferenceO’Sullivan C, Rutten P, Schatz C ( 2020 ) Why Tech Transfer May Be Critical to Beating COVID-19. [Last accessed 19 May 2021.] Available from URL: https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/why-tech-transfer-may-be-critical-to-beating-covid-19.
dc.identifier.citedreferencePreston C, Valdez ML, Bond K ( 2012 ) Strengthening Medical Product Regulation in Low- and Middle-income Countries. PLoS Medicine 9 ( 10 ), e1001327.
dc.identifier.citedreferenceSchweitzer S, Lu Z ( 2018 ) Pharmaceutical Economics and Policy: Perspectives, Promises, and Problems. Oxford University Press, Oxford, UK.
dc.identifier.citedreferenceShadlen K ( 2017 ) Coalitions and Compliance: The Political Economy of Pharmaceutical Patents in Latin America. Oxford University Press, New York.
dc.identifier.citedreferenceSilva AP, Tagiari P ( 2016 ) Iniciativas de convergência regulatória em saúde nas Américas: histórico, evolução e novos desafios. Revista Panamericana de Salud Pública 39, 281 – 287.
dc.identifier.citedreferenceSimpson S, Chakrabarti A, Robinson D, Chirgwin K, Lumpkin M ( 2020 ) Navigating Facilitated Regulatory Pathways during a Disease X Pandemic. npj Vaccines 5 ( 1 ), 101.
dc.identifier.citedreferenceSingh J, Upshur R ( 2020 ) The Granting of Emergency Use Designation to COVID-19 Candidate Vaccines: Implications for COVID-19 Vaccine Trials. The Lancet Infectious Diseases 21 ( 4 ), e103 – e109.
dc.identifier.citedreferenceSubbaro K ( 2020 ) COVID-19 Vaccines: Time to Talk about the Uncertainties. Nature 586, 475.
dc.identifier.citedreferenceTaylor A ( 2020 ) China’s COVID Vaccines are Already Being Distributed. But How Do They Work, and Where are They Up to in Trials? The Conversation, 9 Dec. [Last accessed 19 May 2021.] Available from URL: https://theconversation.com/chinas-covid-vaccines-are-already-being-distributed-but-how-do-they-work-and-where-are-they-up-to-in-trials-151589.
dc.identifier.citedreferenceThacker P ( 2020 ) Conflicts of Interest Among the UK Government’s Covid-19 Advisers. BMJ 371, m4716.
dc.identifier.citedreferenceTorreele E ( 2020 ) The Rush to Create a Covid-19 Vaccine May Do More Harm than Good. BMJ 370, m3209.
dc.identifier.citedreferenceVogel D ( 2012 ) The Politics of Precaution: Regulating Health, Safety, and Environmental Risks in Europe and the United States. Princeton University Press, Princeton, NJ.
dc.identifier.citedreferenceWeyland K ( 2007 ) Bounded Rationality and Policy Diffusion: Social Sector Reform in Latin America. Princeton University Press, Princeton, NJ.
dc.identifier.citedreferenceWolf J, Bruno S, Eichberg M et al. ( 2020 ) Applying Lessons from the Ebola Vaccine Experience for SARS-CoV-2 and Other Epidemic Pathogens. npj Vaccines 5 ( 1 ), 51. https://doi.org/10.1038/s41541-020-0204-7.
dc.identifier.citedreferenceWoll C ( 2008 ) Firm Interests: How Governments Shape Business Lobbying on Global Trade. Cornell University Press, Ithaca, NY/London, UK.
dc.identifier.citedreferenceWoll C ( 2019 ) Corporate Power Beyond Lobbying. American Affairs Journal III ( 3 ), 38 – 55.
dc.identifier.citedreferenceWorld Health Organization ( 2020 ) WHO Target Product Profiles for COVID-19 Vaccines. [Last accessed 19 May 2021.] Available from URL: https://www.who.int/docs/default-source/blue-print/who-target-product-profiles-for-covid-19-vaccines.pdf.
dc.identifier.citedreferenceFreedman L ( 2020 ) Scientific Advice at a Time of Emergency. SAGE and Covid-19. The Political Quarterly 91 ( 3 ), 514 – 522.
dc.identifier.citedreferenceGyawali B, Kesselheim A ( 2018 ) Reinforcing the Social Compromise of Accelerated Approval. Nature Reviews. Clinical Oncology 15 ( 10 ), 596 – 597.
dc.identifier.citedreferenceANVISA ( 2020 ) Uso emergencial de vacinas: Anvisa estabelece prazo de até 10 dias para dar decisão. [Last accessed 19 May 2021.] Available from URL: https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2020/uso-emergencial-de-vacinas-anvisa-estabelece-prazo-de-ate-10-dias-para-dar-decisao.
dc.identifier.citedreferenceBaron, D ( 1993 ) The Economics and Politics of Regulation: Perspectives, Agendas and Approaches. Research Paper No 1247. Stanford University.
dc.identifier.citedreferenceBBC ( 2020a ) Covid: FDA Approves Pfizer Vaccine for Emergency Use in US. [Last accessed 19 May 2021.] Available from URL: https://www.bbc.com/news/world-us-canada-55265477.
dc.identifier.citedreferenceBBC ( 2020b ) Covid: Mexico, Chile and Costa Rica Begin Mass Vaccination. BBC, 25 Dec. [Last accessed 19 May 2021.] Available from URL: https://www.bbc.com/news/world-latin-america-55440940?xtor=AL-72-%5Bpartner%5D-%5Binforadio%5D-%5Bheadline%5D-%5Bnews%5D-%5Bbizdev%5D-%5Bisapi%5D.
dc.identifier.citedreferenceBBC ( 2021 ) Covaxin: Concern over ‘Rushed’ Approval for India Covid Jab. [Last accessed 19 May 2021.] Available from URL: https://www.bbc.com/news/world-asia-india-55526123.
dc.identifier.citedreferenceBenish A, Levi-Faur D ( 2020 ) The Reassertion of the Regulatory Welfare State: A Preface. The Annals of the American Academy of Political and Social Science 691 ( 1 ), 7 – 16. https://doi.org/10.1177/0002716220949216.
dc.identifier.citedreferenceBingham K ( 2021 ) The UK Government’s Vaccine Taskforce: Strategy for Protecting the UK and the World. Lancet 397 ( 10268 ), 68 – 70.
dc.identifier.citedreferenceBoseley S ( 2020 ) How Vaccine Approval Compares between the UK, Europe and the US. The Guardian, 4 Dec. [Last accessed 19 May 2021.] Available from URL: https://www.theguardian.com/world/2020/dec/04/how-vaccine-approval-compares-between-the-uk-europe-and-the-us.
dc.identifier.citedreferenceBreckenridge A, Liberti L ( 2018 ) Accelerated Approval of Medicines: Fit for Purpose? Nature Reviews Drug Discovery 17 ( 6 ), 379 – 380.
dc.identifier.citedreferenceBremmer I ( 2020 ) What Vaccine Nationalism Means for the Coronavirus Pandemic. Time, 27 July. [Last accessed 19 May 2021.] Available from URL: https://time.com/5871532/vaccine-nationalism-coronavirus-pandemic/.
dc.identifier.citedreferenceBurki T ( 2020 ) The Russian Vaccine for COVID-19. The Lancet Respiratory Medicine 8 ( 11 ), e85 – e86.
dc.identifier.citedreferenceCarpenter D ( 2004a ) The Political Economy of FDA Drug Review: Processing, Politics, and Lessons FPR Policy. Health Affairs 23 ( 1 ), 52 – 63.
dc.identifier.citedreferenceCarpenter D ( 2004b ) Protection without Capture: Product Approval by a Politically Responsive, Learning Regulator. American Political Science Review 98 ( 4 ), 613 – 631.
dc.identifier.citedreferenceCarpenter D ( 2010 ) Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA. Princeton University Press, Princeton, NJ.
dc.identifier.citedreferenceCarpenter D, Moss D ( 2013 ) Preventing Regulatory Capture: Special Interest Influence and how to Limit it. Cambridge University Press, Cambridge, UK.
dc.identifier.citedreferenceCyranoski D ( 2020 ) Arab Nations First to Approve Chinese COVID Vaccine – Despite Lack of Public Data. Nature 588, 548.
dc.identifier.citedreferenceDavis C, Abraham J ( 2013 ) Unhealthy Pharmaceutical Regulation: Innovation, Politics and Promissory Science. London: Palgrave Macmillan.
dc.identifier.citedreferenceDepartment for Business Energy & Industrial Strategy ( 2020 ) UK Vaccine Taskforce 2020 Achievements and Future Strategy: End of Year Report. [Last accessed 19 May 2021.] Available from URL: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/944308/VTF_Interim_report_-_5th_publication.pdf.
dc.identifier.citedreferenceDexter L ( 2006 ) Elite and Specialized Interviewing. Ecpr Press, Colchester, UK.
dc.identifier.citedreferenceEuropean Parliamentary Research Service ( 2015 ) The Precautionary Principle: Definitions, Applications, and Governance. [Last accessed 19 May 2021.] Available from URL: https://www.europarl.europa.eu/RegData/etudes/IDAN/2015/573876/EPRS_IDA(2015)573876_EN.pdf.
dc.identifier.citedreferenceFischer A ( 2020 ) The Dark Sides of Social Policy: From Neoliberalism to Resurgent Right-wing Populism. Development and Change 51 ( 2 ), 371 – 397.
dc.identifier.citedreferenceJeantet D, Savarese M ( 2021 ) Brazil Scrambles to Approve Virus Vaccine as Pressure Mounts. ABC News, 1 Jan. [Last accessed 19 May 2021.] Available from URL: https://abcnews.go.com/Health/wireStory/brazil-scrambles-approve-virus-vaccine-pressure-mounts-75001173.
dc.identifier.citedreferenceKhadem Broojerdi A, Baran Sillo H, Ostad Ali Dehaghi R, Ward M, Refaat M, Parry J ( 2020 ) The World Health Organization Global Benchmarking Tool an Instrument to Strengthen Medical Products Regulation and Promote Universal Health Coverage. Frontiers in Medicine 7 ( 457 ), 1 – 7.
dc.identifier.citedreferenceKrause P, Fleming TR, Longini I et al. ( 2020 ) COVID-19 Vaccine Trials Should Seek Worthwhile Efficacy. The Lancet 396 ( 10253 ), 741 – 743.
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
rego12413.pdf
Size:
274.0KB
Format:
PDF
View/Open
Name:
rego12413_am.pdf
Size:
202.2KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.